Amneal Reports Third Quarter 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/28/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. BA
6. SPY
7. META
8. HOOD
9. INTC
10. JBLU

Go back to Amneal Reports Third Quarter 2020 Financial Results

Amneal Pharmaceuticals (AMRX) Tops Q3 EPS by 4c, Revenues Beat; Raises FY20 Revenue Guidance Above Consensus

November 6, 2020 6:10 AM EST

Amneal Pharmaceuticals (: AMRX) reported Q3 EPS of $0.16, $0.04 better than the analyst estimate of $0.12. Revenue for the quarter came in at $519 million versus the consensus estimate of $482.11 million.

Amneal delivered another strong quarter, providing further evidence that our Amneal 2.0 strategy is positioning the company... More